Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Deccox
2. Ethyl-6-(decycloxy)-7-ethoxy-4-hydroxy-3-quinolinecarboxylate
1. 18507-89-6
2. Deccox
3. Decoxy
4. Ethyl 6-(decyloxy)-7-ethoxy-4-hydroxyquinoline-3-carboxylate
5. Hc 1528
6. M&b 15497
7. Nsc 339057
8. Ethyl 6-decoxy-7-ethoxy-4-oxo-1h-quinoline-3-carboxylate
9. Ethyl 6-(decyloxy)-7-ethoxy-4-hydroxy-3-quinolinecarboxylate
10. 3-quinolinecarboxylic Acid, 6-(decyloxy)-7-ethoxy-4-hydroxy-, Ethyl Ester
11. Nsc-339057
12. M And B 15497
13. 534i52pvwh
14. Nsc339057
15. Hc-1528
16. Ncgc00181109-01
17. Decoquinate 100 Microg/ml In Acetonitrile/dmf
18. Dsstox_cid_26851
19. Dsstox_rid_81960
20. Dsstox_gsid_46851
21. 1453100-61-2
22. Decoquinat
23. Decoquinato
24. Decoquinatum
25. Decoquinatum [inn-latin]
26. Decoquinato [inn-spanish]
27. Cas-18507-89-6
28. Ethyl 6-decyloxy-7-ethoxy-4-hydroxy-3-quinolinate
29. Einecs 242-389-1
30. Ethyl 6-decoxy-7-ethoxy-4-hydroxyquinoline-3-carboxylate
31. Unii-534i52pvwh
32. Deccoxtm
33. Decoquinate-[d5]
34. Decoquinate [usan:usp:inn:ban]
35. Deccox (tn)
36. Ethyl 5-decyloxy-7-ethoxy-4-hydroxy-3-chinolincarboxylat
37. Edtadimagnesiumsalt
38. Decoquinate (usp/inn)
39. Decoquinate [mi]
40. Decoquinate [inn]
41. Decoquinate [usan]
42. Decoquinate [mart.]
43. Schembl43853
44. Decoquinate [usp-rs]
45. Chembl416230
46. Decoquinate [green Book]
47. Dtxsid5046851
48. M. And B. 15497
49. Ethyl 6-decyloxy-7-ethoxy-4-hydroxyquinoline-3-carboxylate
50. Ethyl 4-hydroxy-6-(decyloxy)-7-ethoxyquinoline-3-carboxylate
51. Hms2093d11
52. Pharmakon1600-01505356
53. Decoquinate [usp Monograph]
54. Bcp28448
55. Ethyl 6-(n-decyloxy)-7-ethoxy-4-hydroxyquinoline-3-carboxylate
56. Hy-b1036
57. Tox21_112723
58. Mfcd00673686
59. Nsc759109
60. S4145
61. Zinc38139853
62. 6-(decyloxy)-7-ethoxy-4-hydroxy-3-quinolinecarboxylic Acid Ethyl Ester
63. Akos015895953
64. Akos022185844
65. Tox21_112723_1
66. Cs-4555
67. Db11394
68. Nsc-759109
69. Ncgc00181109-03
70. Ncgc00264109-01
71. As-13953
72. Sbi-0206843.p001
73. Db-065512
74. M&b-15497
75. D4192
76. Ft-0657664
77. D03667
78. F21439
79. Ab01563292_01
80. Ab01563292_02
81. Decoquinate, Vetranal(tm), Analytical Standard
82. 507d896
83. A812918
84. Sr-05000001968
85. J-521161
86. Q5249594
87. Sr-05000001968-1
88. Brd-k17641316-001-01-4
89. Ethyl 6-decoxy-7-ethoxy-4-hydroxy-quinoline-3-carboxylate
90. Decoquinate, United States Pharmacopeia (usp) Reference Standard
91. 6-decyloxy-7-ethoxy-4-hydroxy-3-quinolinecarboxylic Acid Ethyl Ester
92. 6-decyloxy-7-ethoxy-4-hydroxyquinoline-3-carboxylic Acid Ethyl Ester
Molecular Weight | 417.5 g/mol |
---|---|
Molecular Formula | C24H35NO5 |
XLogP3 | 6.8 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 15 |
Exact Mass | 417.25152322 g/mol |
Monoisotopic Mass | 417.25152322 g/mol |
Topological Polar Surface Area | 73.9 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 562 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Coccidiostats
Agents useful in the treatment or prevention of COCCIDIOSIS in man or animals. (See all compounds classified as Coccidiostats.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Decoquinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Decoquinate, including repackagers and relabelers. The FDA regulates Decoquinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Decoquinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Decoquinate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Decoquinate supplier is an individual or a company that provides Decoquinate active pharmaceutical ingredient (API) or Decoquinate finished formulations upon request. The Decoquinate suppliers may include Decoquinate API manufacturers, exporters, distributors and traders.
click here to find a list of Decoquinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Decoquinate DMF (Drug Master File) is a document detailing the whole manufacturing process of Decoquinate active pharmaceutical ingredient (API) in detail. Different forms of Decoquinate DMFs exist exist since differing nations have different regulations, such as Decoquinate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Decoquinate DMF submitted to regulatory agencies in the US is known as a USDMF. Decoquinate USDMF includes data on Decoquinate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Decoquinate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Decoquinate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Decoquinate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Decoquinate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Decoquinate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Decoquinate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Decoquinate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Decoquinate suppliers with NDC on PharmaCompass.
Decoquinate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Decoquinate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Decoquinate GMP manufacturer or Decoquinate GMP API supplier for your needs.
A Decoquinate CoA (Certificate of Analysis) is a formal document that attests to Decoquinate's compliance with Decoquinate specifications and serves as a tool for batch-level quality control.
Decoquinate CoA mostly includes findings from lab analyses of a specific batch. For each Decoquinate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Decoquinate may be tested according to a variety of international standards, such as European Pharmacopoeia (Decoquinate EP), Decoquinate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Decoquinate USP).
LOOKING FOR A SUPPLIER?